Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
View ORCID ProfileTrevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
doi: https://doi.org/10.1101/2021.12.22.21268217
Trevor L. Schell
βDepartment of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDKeith L. Knutson
αDepartment of Immunology, Mayo Clinic Jacksonville, Florida, United States
PhDSumona Saha
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MD, MSArnold Wald
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDHiep S Phan
βDepartment of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDMazen Almasry
βDepartment of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MBBSKelly Chun
γLabCorp, R&D and Specialty Medicine
PhDIan Grimes
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDMegan Lutz
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
MDMary S. Hayney
‡School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, United States
PharmD, MPHFrancis A. Farraye
†Inflammatory Bowel Disease Center, Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, United States
MD, MScFreddy Caldera
*Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine & Public Health, Madison, Wisconsin, United States
DO, MS
Data Availability
All data produced in the present work are contained in the manuscript.
Posted December 27, 2021.
Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Trevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
medRxiv 2021.12.22.21268217; doi: https://doi.org/10.1101/2021.12.22.21268217
Humoral Immunogenicity of Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease
Trevor L. Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep S Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney, Francis A. Farraye, Freddy Caldera
medRxiv 2021.12.22.21268217; doi: https://doi.org/10.1101/2021.12.22.21268217
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (728)
- Anesthesia (215)
- Cardiovascular Medicine (3126)
- Dermatology (265)
- Emergency Medicine (464)
- Epidemiology (13076)
- Forensic Medicine (14)
- Gastroenterology (868)
- Genetic and Genomic Medicine (4895)
- Geriatric Medicine (451)
- Health Economics (755)
- Health Informatics (3089)
- Health Policy (1109)
- Hematology (411)
- HIV/AIDS (973)
- Medical Education (457)
- Medical Ethics (121)
- Nephrology (502)
- Neurology (4664)
- Nursing (248)
- Nutrition (691)
- Oncology (2405)
- Ophthalmology (683)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (311)
- Palliative Medicine (88)
- Pathology (519)
- Pediatrics (1249)
- Primary Care Research (526)
- Public and Global Health (7231)
- Radiology and Imaging (1613)
- Respiratory Medicine (945)
- Rheumatology (462)
- Sports Medicine (403)
- Surgery (518)
- Toxicology (65)
- Transplantation (222)
- Urology (193)